These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16246668)

  • 1. Risks of mifepristone abortion in context.
    McGregor JA; Equiles O
    Contraception; 2005 Nov; 72(5):393; author reply 394. PubMed ID: 16246668
    [No Abstract]   [Full Text] [Related]  

  • 2. Fatal infections associated with mifepristone-induced abortion.
    Greene MF
    N Engl J Med; 2005 Dec; 353(22):2317-8. PubMed ID: 16319378
    [No Abstract]   [Full Text] [Related]  

  • 3. infectious disease. RU-486-linked deaths open debate about risky bacteria.
    Couzin J
    Science; 2006 May; 312(5776):986. PubMed ID: 16709757
    [No Abstract]   [Full Text] [Related]  

  • 4. Risks of mifepristone abortion in context.
    Grimes DA
    Contraception; 2005 Mar; 71(3):161. PubMed ID: 15722063
    [No Abstract]   [Full Text] [Related]  

  • 5. Toxic shock associated with Clostridium sordellii and Clostridium perfringens after medical and spontaneous abortion.
    Cohen AL; Bhatnagar J; Reagan S; Zane SB; D'Angeli MA; Fischer M; Killgore G; Kwan-Gett TS; Blossom DB; Shieh WJ; Guarner J; Jernigan J; Duchin JS; Zaki SR; McDonald LC
    Obstet Gynecol; 2007 Nov; 110(5):1027-33. PubMed ID: 17978116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deaths from Clostridium sordellii after medical abortion.
    Sicard D
    N Engl J Med; 2006 Apr; 354(15):1645-7; author reply 1645-7. PubMed ID: 16615188
    [No Abstract]   [Full Text] [Related]  

  • 7. Risks of mifepristone abortion in context.
    Crockett SA
    Contraception; 2006 Aug; 74(2):174; author reply 175-6. PubMed ID: 16860057
    [No Abstract]   [Full Text] [Related]  

  • 8. Risks of mifepristone abortion in context.
    Grimes DA
    Contraception; 2006 Aug; 74(2):174-5 author reply175-6. PubMed ID: 16860058
    [No Abstract]   [Full Text] [Related]  

  • 9. Deaths from Clostridium sordellii after medical abortion.
    Zane SB; Berg CJ
    N Engl J Med; 2006 Apr; 354(15):1645-7; author reply 1645-7. PubMed ID: 16615187
    [No Abstract]   [Full Text] [Related]  

  • 10. Deaths from Clostridium sordellii after medical abortion.
    Baulieu EE
    N Engl J Med; 2006 Apr; 354(15):1645-7; author reply 1645-7. PubMed ID: 16611961
    [No Abstract]   [Full Text] [Related]  

  • 11. Public health advisory for mifepristone.
    FDA Consum; 2005; 39(5):4-5. PubMed ID: 16421985
    [No Abstract]   [Full Text] [Related]  

  • 12. Clostridium sordellii toxic shock syndrome after medical abortion with mifepristone and intravaginal misoprostol--United States and Canada, 2001-2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Jul; 54(29):724. PubMed ID: 16049422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatal Clostridium sordellii infections after medical abortions.
    Meites E; Zane S; Gould C;
    N Engl J Med; 2010 Sep; 363(14):1382-3. PubMed ID: 20879895
    [No Abstract]   [Full Text] [Related]  

  • 14. Clostridium sordellii infection in medical abortion.
    Winikoff B
    Clin Infect Dis; 2006 Dec; 43(11):1447-8. PubMed ID: 17083019
    [No Abstract]   [Full Text] [Related]  

  • 15. Medical vs. surgical management of early pregnancy failure.
    Shukunami K; Nishijima K; Kotsuji F
    N Engl J Med; 2005 Dec; 353(22):2403-4; author reply 2403-4. PubMed ID: 16319392
    [No Abstract]   [Full Text] [Related]  

  • 16. Septic shock after medical abortions with mifepristone (Mifeprex, RU 486) and misoprostol.
    Murray S; Wooltorton E
    CMAJ; 2005 Aug; 173(5):485. PubMed ID: 16093445
    [No Abstract]   [Full Text] [Related]  

  • 17. Fatal toxic shock syndrome associated with Clostridium sordellii after medical abortion.
    Fischer M; Bhatnagar J; Guarner J; Reagan S; Hacker JK; Van Meter SH; Poukens V; Whiteman DB; Iton A; Cheung M; Dassey DE; Shieh WJ; Zaki SR
    N Engl J Med; 2005 Dec; 353(22):2352-60. PubMed ID: 16319384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on medication abortion.
    Beal MW
    J Midwifery Womens Health; 2007; 52(1):23-30. PubMed ID: 17207747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comment: analysis of severe adverse events related to the use of mifepristone as an abortifacient.
    Svedas E; Maciulaitis R; Stakisaitis D
    Ann Pharmacother; 2006 Apr; 40(4):784; author reply 784-5. PubMed ID: 16595574
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety of mifepristone abortions in clinical use.
    Henderson JT; Hwang AC; Harper CC; Stewart FH
    Contraception; 2005 Sep; 72(3):175-8. PubMed ID: 16102550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.